ARBUTUS BIOPHARMA CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.88 USD | -2.04% |
|
+6.27% | +15.20% |
| May. 09 | Whitefort Capital Management Engages with Arbutus Biopharma | CI |
| May. 02 | Transcript : Arbutus Biopharma Corporation, Q1 2024 Earnings Call, May 02, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Biopharmaceuticals | -2.04% | +6.27% | +15.20% | +12.50% | +22.55% | 544M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ABUS Stock
- Charts Arbutus Biopharma Corporation
- Comparison Chart
